Advertisement XTend Medical to start diabetic patient monitoring program - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

XTend Medical to start diabetic patient monitoring program

XTend Medical, a provider of telemedicine solutions to the healthcare industry, has signed an agreement to begin a remote diabetic patient monitoring program with AmeriChoice, a division of United Health Group, a US-based healthcare provider.

Paul Lisenby, CEO of XTend Medical, said: “This agreement will deliver to AmeriChoice a comprehensive solution that will allow their diabetic patients to be remotely monitored and communicate results in order to effectively assist patients in managing their diabetes.

“This clearly distances XTend Medical from our competition. With this agreement in place, XTend Medical is in a very advantageous position in the marketplace.”